In this episode, 2 experts discuss the evolving role of weekly insulin therapy in modern type 2 diabetes (T2D) management. They share practical considerations for initiating or switching to these novel agents, including how to accurately convert daily doses, follow titration schedules, and support adherence and patient preferences through shared decision-making. Learn how you can ensure optimized glycemic control and reduced treatment burden in your patients with T2D by integrating weekly insulin therapies in your endocrinology, diabetology, or primary care practice.

Presenters

Richard E. Pratley, MD

Jay H. Shubrook, DO, FAAFP, FACOFP

Link to full program: 
https://bit.ly/4wyjOg7

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Two experts in obesity medicine discuss the latest advances in obesity care, including:

[JF1]Added this to the episode notes to maybe help with the posttest 

Presenters

Nicholas Pennings, DO

Link to full program:
https://bit.ly/4v7eIY4

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Four inflammatory bowel disease (IBD) experts explore case-based strategies for optimizing advanced IBD therapy and long-term disease management early in real-world practice. They discuss practical approaches for implementing treat-to-target via strategic treatment sequencing, therapeutic drug monitoring, and maintenance approaches while supporting individualized, evidence-based care for patients with IBD.

Presenters

Jessica R. Allegretti, MD, MPH, FACG, AGAF

Jordan E. Axelrad, MD, MPH, AGAF, FACG, FCCF

Russell D. Cohen, MD, FACG, AGAF

Amy Stewart, MSN, FNP-C

Link to full program: 
https://bit.ly/4wvm7l4

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

As current understandings of obesity (ie, a chronic disease requiring long-term management) are adopted across the world, screening and treatment can no longer follow a one-size-fits-all approach. Listen in as 3 global experts in obesity medicine highlight the emerging evidence from recent conferences that are changing real-world practice today. Learn how the latest findings apply to specific patient populations across the United States, Europe, and Asia as well as why healthcare professionals should individualize treatment based on patient preferences and relevant risk factors.

Presenters:

Stephano Del Prato, MD

Soo Lim, MD, PhD

Donna H. Ryan, MD

Link to full program:
https://bit.ly/4pwFhEo

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

With this podcast, featuring audio from a Medical Minute webcast, expert faculty Maria Londoño, MD, PhD, discusses how recent clinical trial and real-world data can improve treatment plans for patients with PBC. Listen now and visit the program page to download the accompanying slides.

Topics covered include:

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters: 

Maria Londoño, MD, PhD

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast, Jennifer Green, MD, and Jay H. Shubrook, DO, FAAFP, FACOFP, share strategies for integrating incretin-based therapies in type 2 diabetes (T2D) management in the primary care setting, including:

Presenters:

Jennifer Green, MD

Jay H. Shubrook, DO, FAAFP, FACOFP

Full program link: 
https://bit.ly/4uSKCqv

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice. 

Topics covered include:

• Treatment Goals
• Long-term Data With PPAR Agonists
• Investigational Therapies for Pruritus

Presenter: 

Nancy Reau, MD
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois

To download the accompanying slides, visit the program page for this episode: 
https://bit.ly/4b2d6YD

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including:

• The Lancet Commission’s new obesity definitions and diagnostic criteria
• Key data on incretin-based antiobesity medications like semaglutide and tirzepatide
• Best practices for patient discussions
• Strategies for incorporating new evidence in your primary care practice

Presenters
Jay H. Shubrook, DO, FACOFP, FAAFP
Professor and Diabetologist
Department of Clinical Sciences and Community Health
Touro University California College of Osteopathic Medicine
Vallejo, California

Christopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA
Bariatric Services Medical Director, Ascension Wisconsin
Obesity Medicine Director, Ascension Columbia St Mary’s Bariatric Center
Trustee, Obesity Medicine Association
Adjunct Assistant Professor of Pediatrics
Medical College of Wisconsin
Milwaukee, Wisconsin

Link to full program:
https://bit.ly/4rG7QQp

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help.

Topics covered include:

• Mechanisms of pruritus and fatigue in PBC
• Nonpharmacologic treatment options
• An overview of clinical trial data supporting second-line agents for symptom management:
• Bezafibrate
• Elafibranor
• Seladelpar
• Investigational agents:
• Volixibat
• Linerixibat
• Setanaxib

This episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode:
https://bit.ly/44ZJ5os

Presenters:
Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD, 
MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals.

Topics covered include:

• Available agents for second-line treatment of PBC 
• An overview of clinical trial data supporting second-line agents:
• Obeticholic acid (OCA)
• Bezafibrate
• Elafibranor
• Seladelpar

This episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r

Presenters:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD, MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.